A groundbreaking study has identified an inherited gene mutation that significantly increases the risk of prostate cancer in families with a history ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Risk for prostate cancer due to pathogenic WNT9B mutation is comparable to risk of breast cancer conferred by pathogenic mutations that are routinely tested for breast cancer care. Knowledge of ...

Van Andel Institute researchers discovered that cancer risk may be determined before birth due to distinct epigenetic states ...

The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to a new study.

The genetic underpinnings of prostate cancer play a significant role in its development and progression. Research has identified specific genetic mutations, most notably in the BRCA1 and BRCA2 ...

A pathogenic gene mutation is a change in the DNA sequence ... Established high-risk prostate cancer genes now include WNT9B, HOXB13 (also functioning in embryonic prostate development), the ...

The findings could lead to genetic tests that predict the likelihood of disease recurrence in breast cancer patients and ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

and funded by Prostate Cancer UK. Taking a novel approach to screening Multiple genetic mutations have already been associated with prostate cancer, but it has proven difficult to distinguish between ...